MUMBAI, March 3 (Reuters) - Panacea Biotec said on Wednesday it has signed an advance market agreement with the Government of India to manufacture Pandyflu, the firm's swine flu vaccine.

While the traditional flu season may be winding down, the H1N1 swine flu is still a threat.

A new swine flu case has been reported in Himachal Pradesh after a gap of over a month, a health department official said here on Wednesday.